Michael J. Valentino, President & CEO at Adams Respiratory Therapeutics, Inc. (ARXT), sold 17,891 shares at $38.01 ($684K) on 2007-10-01, disclosed to the SEC on 2007-10-03.
Scheduled sale ($684k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.95 | 501 | $19K | 2.8% |
| 2 | $37.96 | 200 | $8K | 1.1% |
| 3 | $37.98 | 100 | $4K | 0.6% |
| 4 | $38.01 | 3,199 | $122K | 17.8% |
| 5 | $38.02 | 2,000 | $76K | 11.1% |
| 6 | $38.04 | 600 |
| $23K |
| 3.3% |
| 7 | $38.09 | 300 | $11K | 1.7% |
| 8 | $38.12 | 200 | $8K | 1.1% |
| 9 | $38.13 | 500 | $19K | 2.8% |
| 10 | $38.15 | 1,500 | $57K | 8.4% |
| 11 | $38.17 | 400 | $15K | 2.2% |
| 12 | $38.24 | 200 | $8K | 1.1% |
| 13 | $38.25 | 100 | $4K | 0.6% |
| 14 | $38.26 | 100 | $4K | 0.6% |
| 15 | $38.29 | 1,091 | $42K | 6.1% |
| 16 | $38.30 | 800 | $31K | 4.5% |
| 17 | $38.34 | 800 | $31K | 4.5% |
| 18 | $38.36 | 400 | $15K | 2.2% |
| 19 | $38.37 | 1,100 | $42K | 6.2% |
| 20 | $38.38 | 300 | $12K | 1.7% |
| 21 | $38.39 | 100 | $4K | 0.6% |
| 22 | $38.41 | 300 | $12K | 1.7% |
| 23 | $38.42 | 600 | $23K | 3.4% |
| 24 | $38.44 | 100 | $4K | 0.6% |
| 25 | $38.45 | 400 | $15K | 2.3% |
| 26 | $38.46 | 500 | $19K | 2.8% |
| 27 | $38.47 | 800 | $31K | 4.5% |
| 28 | $38.48 | 500 | $19K | 2.8% |
| 29 | $38.49 | 100 | $4K | 0.6% |
| 30 | $38.50 | 100 | $4K | 0.6% |
| Total | $38.20 avg | 17,891 | $684K | 100% |
| Filing → |
| PLXP | BUY | 2020-11-20 | $1.0M | — | Filing → |
| PLXP | BUY | 2019-05-21 | $497K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $400K | — | Filing → |